News

Surgery adds little after successful chemo in metastatic breast cancer


 

SAN ANTONIO – In patients with metastatic breast cancer who responded favorably to initial chemotherapy, radiotherapy and surgical removal of primary tumors failed to enhance overall survival, a new study has shown.

In an interview at the San Antonio Breast Cancer Symposium, study investigator Dr. Rajendra Badwe offers his perspectives on loco-regional treatment vs. chemotherapy alone, and he discusses why surgical removal of primary tumors might be linked to later spread of metastatic disease.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

Genetic profiling transforms cancer treatment trials
MDedge ObGyn
VIDEO: Genetic profiling transforms cancer treatment trials
MDedge ObGyn
Walking program eased chemo-related joint pain
MDedge ObGyn
Surgery may benefit elderly women with endometrial cancer
MDedge ObGyn
Pathologic complete response to HER2 therapy portends better outcomes
MDedge ObGyn
Radiotherapy can be omitted for many older breast cancer patients
MDedge ObGyn
VIDEO: Tumor-infiltrating lymphocytes may predict trastuzumab success
MDedge ObGyn
Dasatinib gives letrozole a boost in HR-positive advanced breast cancer
MDedge ObGyn
IBIS-II: Anastrozole highly effective in preventing breast cancer
MDedge ObGyn
No gain seen from adjuvant bevacizumab in HER2-positive disease
MDedge ObGyn